Personalizing Approaches to IBD Therapy

Target Audience

This activity has been designed to meet the educational needs of gastroenterologists, physician assistants, and nurse practitioners involved in the management of IBD.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Utilize presentation and prognosis to personalize treatment strategies

Optimize conventional therapies (dosing, therapeutic monitoring of thiopurine drugs) in Ulcerative Colitis and Crohn's Disease

Optimize biologic therapies to achieve mucosal healing and maintain deep remissions in Ulcerative Colitis and Crohn's Disease

Physician Disclosure Statement

Douglas Wolf, MD has disclosed that he is a consultant for Abbvie, Elan Pharmaceuticals, Genentech, GIVEN imaging, Janssen Biotech, Inc., Prometheus Laboratories, Salix Pharmaceuticals, Inc., UCB Pharma and Warner Chilcott. He has served on the speaker’s bureau for Abbvie, Janssen Biotech, Inc., Prometheus Laboratories, Santaris, Salix Pharmaceuticals, Inc., Shire Pharmaceuticals and UCB Pharma. He has disclosed other financial material support for research from Abbvie, Elan Pharmaceuticals, GIVEN imaging, GlaxoSmithKane, Genentech, Janssen, Millennium Pharmaceuticals, Phizer, Prometheus Laboratories, Receptos, Shire Pharmaceuticals, Tsumura and UCB Pharma.

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Annenberg Center for Health Sciences at Eisenhower and Gi Health Foundation. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with
the extent of their participation in the activity.

Faculty Disclosure Statement

It is the policy of the Annenberg Center to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.

The Annenberg Center assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME/CE activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center policy, the following disclosures have been made:

Release Date: May 13, 2013Expiration Date: May 13, 2014  
*This program has expired. CME credit is no longer available.